T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Humana
HUM
|
+$2.39B |
| 2 |
UnitedHealth
UNH
|
+$1.47B |
| 3 |
GE Aerospace
GE
|
+$1.33B |
| 4 |
Amazon
AMZN
|
+$1.18B |
| 5 |
AbbVie
ABBV
|
+$1.13B |
Top Sells
| 1 |
Boeing
BA
|
+$1.56B |
| 2 |
Nike
NKE
|
+$1.42B |
| 3 |
Becton Dickinson
BDX
|
+$1.33B |
| 4 |
Alibaba
BABA
|
+$1.23B |
| 5 |
JPMorgan Chase
JPM
|
+$1.22B |
Sector Composition
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.27% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
976
Karyopharm Therapeutics
KPTI
$53.8M
| $26.8M | ﹤0.01% |
92,983
+81,666
| +722% | +$23.5M |
|
977
Ingevity
NGVT
$2.08B
| $26.7M | ﹤0.01% |
758,592
-4,866
| -0.6% | -$171K |
|
|
EVOP
978
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $26.6M | ﹤0.01% |
1,736,740
+29,243
| +2% | +$447K |
|
979
Amcor
AMCR
$19B
| $26.5M | ﹤0.01% |
3,265,937
+241,660
| +8% | +$1.96M |
|
980
CBRE Group
CBRE
$48.4B
| $26.4M | ﹤0.01% |
699,578
+51,203
| +8% | +$1.93M |
|
981
Hewlett Packard
HPE
$32.8B
| $26.4M | ﹤0.01% |
2,715,809
+258,503
| +11% | +$2.51M |
|
982
Evergy
EVRG
$16.5B
| $26.3M | ﹤0.01% |
478,589
-1,971,557
| -80% | -$109M |
|
983
Extra Space Storage
EXR
$31.5B
| $26.2M | ﹤0.01% |
274,106
+20,454
| +8% | +$1.96M |
|
984
Equity Bancshares
EQBK
$809M
| $26.2M | ﹤0.01% |
1,519,115
-1,427
| -0.1% | -$24.6K |
|
985
John B. Sanfilippo & Son
JBSS
$724M
| $26.1M | ﹤0.01% |
291,556
+7,277
| +3% | +$651K |
|
986
LyondellBasell Industries
LYB
$17.8B
| $26M | ﹤0.01% |
523,952
+36,813
| +8% | +$1.83M |
|
987
NeoGenomics
NEO
$966M
| $25.9M | ﹤0.01% |
939,543
+881,841
| +1,528% | +$24.3M |
|
988
Prestige Consumer Healthcare
PBH
$3.2B
| $25.9M | ﹤0.01% |
706,800
-153,962
| -18% | -$5.65M |
|
989
Universal Health Services
UHS
$11.8B
| $25.9M | ﹤0.01% |
261,656
+14,370
| +6% | +$1.42M |
|
990
Perdoceo Education
PRDO
$2.16B
| $25.9M | ﹤0.01% |
2,400,685
+34,974
| +1% | +$377K |
|
991
Best Buy
BBY
$16.1B
| $25.9M | ﹤0.01% |
453,756
+37,115
| +9% | +$2.12M |
|
992
J.M. Smucker
SJM
$11.8B
| $25.6M | ﹤0.01% |
230,283
+18,289
| +9% | +$2.03M |
|
993
Boyd Gaming
BYD
$6.84B
| $25.5M | ﹤0.01% |
1,770,542
-91,450
| -5% | -$1.32M |
|
994
Quanterix
QTRX
$201M
| $25.5M | ﹤0.01% |
1,387,324
-57,110
| -4% | -$1.05M |
|
995
iShares Russell 1000 Value ETF
IWD
$64.2B
| $25.1M | ﹤0.01% |
+253,200
| New | +$25.1M |
|
996
Nektar Therapeutics
NKTR
$916M
| $25.1M | ﹤0.01% |
93,641
+27,971
| +43% | +$7.49M |
|
997
First American
FAF
$6.74B
| $25M | ﹤0.01% |
590,220
+222,147
| +60% | +$9.42M |
|
998
Mid-America Apartment Communities
MAA
$16.6B
| $24.9M | ﹤0.01% |
241,649
+19,414
| +9% | +$2M |
|
999
Labcorp
LH
$22.7B
| $24.7M | ﹤0.01% |
227,082
+17,719
| +8% | +$1.92M |
|
|
ABMD
1000
DELISTED
Abiomed Inc
ABMD
| $24.6M | ﹤0.01% |
169,138
-718,153
| -81% | -$104M |
|